Recent advances showcase the growing role of artificial intelligence in cancer detection and treatment research. Tahoe Therapeutics raised $30 million aiming to build AI models of living human cells to accelerate drug discovery, joining large-scale data initiatives like the Chan Zuckerberg Initiative. Meanwhile, researchers at Oregon Health and Science University developed AI algorithms capable of analyzing voice recordings to detect laryngeal cancer non-invasively. These acoustic biomarkers differentiate benign from cancerous vocal cord lesions, potentially offering accessible screening for underserved populations. Both developments underscore AI’s expanding footprint in oncology and diagnostics, with implications for precision medicine and early detection.